PBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Pitney Bowes Inc (PBI) is not a strong buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with declining revenue, net income, and EPS. The technical indicators show no clear bullish signals, and hedge funds are selling the stock. While there is some positive sentiment from analysts and a compelling valuation, the risks from declining mailing volumes and lack of strong trading signals make it prudent to hold off on buying this stock right now.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 33.674, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 10.139), with resistance at R1: 10.793. Overall, technical indicators suggest a lack of strong upward momentum.
Analysts from Citizens JMP rate the stock as Outperform with a $13 price target, citing its market leadership and shareholder-friendly actions. Gross margin has improved slightly YoY.
Hedge funds are selling heavily, with a 713.33% increase in selling activity last quarter. Financials show a significant YoY decline in revenue (-7.97%), net income (-137.53%), and EPS (-138.96%). The MACD and RSI indicate no bullish momentum, and the stock faces headwinds from declining mailing volumes.
In Q3 2025, revenue dropped to $459.68M (-7.97% YoY), net income fell to $51.96M (-137.53% YoY), and EPS declined to $0.30 (-138.96% YoY). Gross margin increased slightly to 53.14% (+1.51% YoY). Overall, the financial performance is weak, with significant declines in key metrics.
Analysts are mixed. Truist initiated coverage with a Hold rating and an $11 price target, citing flat earnings and risks from declining mailing volumes. Citizens JMP rated the stock Outperform with a $13 price target, highlighting its market leadership and shareholder-friendly actions.
